Filing Details

Accession Number:
0000904454-11-000642
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-30 21:00:11
Reporting Period:
2009-02-20
Filing Date:
2011-11-30
Accepted Time:
2011-11-30 21:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
932372 Orange 21 Inc. ORNG Ophthalmic Goods (3851) 330580186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1071036 W Seth Hamot C/O Rrh Capital Management Inc.
222 Berkeley Street - 17Th Floor
Boston MA 02116
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2009-02-20 6,000 $0.80 12,000 No 4 P Indirect Held by Reporting Person's children.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Reporting Person's children.
Footnotes
  1. These shares are held in two separate accounts for the Reporting Person's minor children.
  2. As of the date hereof the Reporting Person directly beneficially owns 32,918 shares of Common Stock and also indirectly beneficially owns (i) an aggregate 6,000 shares of Common Stock held in two trusts for the benefit of his children and (ii) 6,318,004 shares of Common Stock that are directly beneficially owned by Costa Brava Partnership III L.P. The Reporting Person is the President and sole member of Roark, Rearden & Hamot, LLC, which is the sole general partner of Costa Brava Partnership III L.P. Pursuant to Instruction 4(b)(iv) of Form 4, Roark, Rearden & Hamot, LLC and Seth W. Hamot have elected to report as indirectly beneficially owned the entire number of securities owned by such limited partnership, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed its or his pecuniary interest therein and/or that are not actually distributed to it or him.